Medicine and Dentistry
Bloodstream Infection
100%
Infection
68%
Antibiotic Resistance
67%
Prevalence
50%
Third Generation Cephalosporin
38%
Cephalosporin Resistance
34%
Retrospective Study
34%
Extended Spectrum Beta Lactamase
31%
Antibiotics
28%
Cross Sectional Study
26%
Escherichia coli
25%
Blood Culture
24%
Tertiary Care
24%
Enterobacteriaceae
23%
4 Iodo 2,5 Dimethoxyamphetamine
23%
Trichomoniasis
23%
Odds Ratio
23%
Gram-Negative Bacteria
20%
Pathogen
20%
Antiinfective Agent
19%
Klebsiella pneumoniae
17%
Escherichia Coli Pneumonia
15%
Hospital Infection
14%
Cefotaxime
14%
Gentamicin
14%
Mixed Infection
14%
Antibiotic Therapy
14%
Study Participant
13%
Salmonella
13%
Serotype
13%
Beta-Lactamase
12%
Ampicillin
12%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Quinolone Derivative
11%
Periodontitis
11%
Herpesviridae
11%
Prostate Biopsy
11%
Hand Hygiene
11%
Trichomonas vaginalis
11%
Bacteriuria
11%
Virulence Factor
11%
Intervention Study
11%
Attitude
11%
Aggressive Periodontitis
11%
Diagnosis
11%
Hemoglobin Determination
11%
Helminth
11%
Outpatient
11%
Patient Referral
11%
Pediatrics
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
90%
Antibiotics
79%
Infection
76%
Antibiotic Resistance
67%
Bloodstream Infection
65%
Extended Spectrum Beta Lactamase
50%
Antiinfective Agent
37%
Enterobacteriaceae
23%
Gram Negative Bacterium
22%
Infectious Agent
22%
Hospital Infection
20%
Malaria Falciparum
17%
Cross-Sectional Study
15%
Disease
15%
Antimicrobial Resistance
15%
Gentamicin
14%
Plasmodium
14%
Mixed Infection
14%
Salmonella
13%
Cefotaxime
13%
Penicillinase
12%
Cloxacillin
12%
Urinary Tract Infection
12%
Beta Lactamase
12%
Community Acquired Infection
12%
Ampicillin
12%
Cefuroxime
11%
Trichomonas vaginalis
11%
Trichomoniasis
11%
Periodontitis
11%
Herpesviridae
11%
Aggressive Periodontitis
11%
Cross Sectional Study
11%
Helminth
11%
Malignant Neoplasm
11%
Retrospective Study
11%
Carbapenemase
11%
Amoxicillin
10%
Defined Daily Dose
9%
Clavulanic Acid
9%
Ceftriaxone
9%
Meropenem
8%
Escherichia coli
8%
Third Generation Cephalosporin
7%
Amikacin
7%
Metronidazole
7%
Ciprofloxacin
7%
Surgical Prophylaxis
7%
Chronic Periodontitis
6%
Human Alphaherpesvirus 1
6%
Immunology and Microbiology
Enterobacterales
80%
Escherichia coli
64%
Infection
46%
Prevalence
43%
Enterobacteriaceae
43%
Antibiotic Resistance
39%
Antimicrobial Resistance
38%
Klebsiella pneumoniae
35%
Infectious Agent
30%
Gram-Negative Bacteria
27%
Serotype
25%
Cephalosporin Resistance
23%
Foot
23%
Antibiotic Sensitivity
22%
Staphylococcus Aureus
20%
Whole Genome Sequencing
15%
Salmonella
14%
Multidrug Resistance
13%
Disk Diffusion
12%
Plasmodium falciparum
11%
Schistosomiasis
11%
Conjugate Vaccine
11%
Plasmodium
11%
Trichomonas vaginalis
11%
Beta-Lactam Resistance
11%
Rural Population
11%
Blood Flow
11%
Human Immunodeficiency Virus
11%
Coinfection
11%
Urinary Tract
11%
Coagulase Negative Staphylococcus
11%
House fly
11%
One Health
11%
Polymerase Chain Reaction
10%
Plasmid
8%
Matrix-Assisted Laser Desorption-Ionization
7%
Klebsiella
6%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
6%
Methicillin-Resistant Staphylococcus Aureus
5%
Pneumococcal Vaccine
5%
Hemoglobin Blood Level
5%
HIV/AIDS
5%
Antimalarial Agent
5%
Streptococcus Pneumonia
5%
Streptococcus
5%